Patient Characteristics
| Characteristic | Total (n = 214) | TACE (n = 153) | CCRT (n = 61) | P |
| Age (y)* | 58 (27–88) | 59 (27–88) | 60 (39–80) | 0.400 |
| Sex | 0.738 | |||
| Men | 180 (84.1%) | 130 (85.0%) | 50 (82.0%) | |
| Women | 34 (15.9%) | 23 (15.0%) | 11 (18.0%) | |
| Diabetes mellitus | 58 (27.1%) | 39 (25.5%) | 19 (31.1%) | 0.503 |
| Etiology | 0.388 | |||
| HBV | 152 (71.0%) | 110 (71.9%) | 42 (68.9%) | |
| HCV | 17 (7.9%) | 12 (7.8%) | 5 (8.2%) | |
| Alcohol | 19 (8.9%) | 16 (10.5%) | 3 (4.9%) | |
| Other | 26 (12.1%) | 15 (9.8%) | 11 (18.0%) | |
| Child–Pugh classification | 0.266 | |||
| A | 182 (85.0%) | 127 (83.0%) | 55 (90.2%) | |
| B | 32 (15.0%) | 26 (17.0%) | 6 (9.8%) | |
| Tumor size (cm)* | 8.0 (1.3–20.0) | 6.3 (1.3–17.6) | 10.0 (2.5–20.0) | <0.001 |
| Tumor number | <0.001 | |||
| Single | 76 (35.5%) | 39 (25.5%) | 37 (60.7%) | |
| Multiple | 138 (64.5%) | 114 (74.5%) | 24 (39.3%) | |
| Portal vein tumor thrombosis | 0.003 | |||
| Absence | 106 (49.5%) | 86 (56.2%) | 20 (32.8%) | |
| Presence | 108 (50.5%) | 67 (43.8%) | 41 (67.2%) | |
| Serum AFP (ng/dL)* | 427.3 (1.6–435,220.0) | 325.7 (2.7–435,220.0) | 1,059.0 (1.6–120,000.0) | 0.853 |
| TLR* | 2.6 (1.1–11.6) | 2.2 (1.1–9.8) | 3.3 (1.3–11.6) | 0.007 |
↵* Data are median value, with range in parentheses.
HBV = hepatitis B virus; HCV = hepatitis C virus.